Smith; Kathryn Jane

Patent Applications and Registrations

Patent applications and USPTO patent grants for Smith; Kathryn Jane.The latest application filed is for "bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors".

Company Profile

0.13.16

Smith; Kathryn Jane - Stevenage GB
SMITH; KATHRYN JANE - Bishop's Storford GB
Smith; Kathryn Jane - Hertfordshire GB
Smith; Kathryn Jane - Bishop's Stortford GB
Smith; Kathryn Jane - Herts GB

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors App 20160339027 - Carter; Malcolm Clive ; et al.	2016-11-24
Bicyclic Heteroaromatic Compounds As Protein Tyrosine Kinase Inhibitors App 20160051551 - Carter; Malcolm Clive ; et al.	2016-02-25
Compounds And Methods Of Treatment App 20110053934 - ANGELL; RICHARD MARTYN ; et al.	2011-03-03
Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors App 20100120804 - Carter; Malcom Clive ; et al.	2010-05-13
5-Acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors Grant 7,432,289 - Angell , et al. October 7, 2	2008-10-07
Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors Grant 7,425,555 - Angell , et al. September 16, 2	2008-09-16
Heterocyclic Compounds App 20070238875 - CARTER; Malcolm Clive ; et al.	2007-10-11
2'-Methyl-5'-(1,3,4-Oxadiazol-2-yl)-1,1'-Biphenyl-4-Carboxamide Derivatives and Their Use As P38 Kinase Inhibitors App 20070112046 - Angell; Richard Martyn ; et al.	2007-05-17
5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors Grant 7,208,629 - Angell , et al. April 24, 2	2007-04-24
2'-Methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors Grant 7,166,623 - Angell , et al. January 23, 2	2007-01-23
Heterocyclic Compounds App 20070015775 - Carter; Malcom Clive ; et al.	2007-01-18
Heterocyclic compounds Grant 7,109,333 - Carter , et al. September 19, 2	2006-09-19
Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors App 20060089393 - Angell; Richard Martyn ; et al.	2006-04-27
Heterocyclic compounds App 20050130996 - Carter, Malcolm Clive ; et al.	2005-06-16
2'-Methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors App 20050090491 - Angell, Richard Martyn ; et al.	2005-04-28
Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors App 20050065195 - Angell, Richard Martyn ; et al.	2005-03-24
5'-Carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors App 20040267012 - Angell, Richard Martyn ; et al.	2004-12-30
Heterocyclic compounds Grant 6,828,320 - Cockerill , et al. December 7, 2	2004-12-07
5-acylamino-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors App 20040242868 - Angell, Richard Martyn ; et al.	2004-12-02
Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors Grant 6,727,256 - Carter , et al. April 27, 2	2004-04-27
Protein tyrosine kinase inhibitors Grant 6,723,726 - Cockerill , et al. April 20, 2	2004-04-20
Heterocyclic compounds Grant 6,713,485 - Carter , et al. March 30, 2	2004-03-30
Heterocyclic compounds App 20030176451 - Carter, Malcolm Clive ; et al.	2003-09-18
Heterocyclic compounds App 20020147214 - Cockerill, George Stuart ; et al.	2002-10-10
Heterocyclic compounds App 20020147205 - Carter, Malcolm Clive ; et al.	2002-10-10
Fused heterocyclic compounds as protein tyrosine kinase inhibitors Grant 6,391,874 - Cockerill , et al.	2002-05-21
Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors Grant 6,207,669 - Cockerill , et al. March 27, 2	2001-03-27
Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors Grant 6,174,889 - Cockerill , et al. January 16, 2	2001-01-16
Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors Grant 6,169,091 - Cockerill , et al. January 2, 2	2001-01-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.